Main Street Financial Solutions’s ARK Genomic Revolution ETF ARKG Stock Holding History

Main Street Financial Solutions’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,288	Closed	-$201K	–	443
2021 Q4	$201K	Sell	3,288 -82	-2%	-$5.67K	0.03%	452
2021 Q3	$252K	Buy	3,370 +401	+14%	+$33.6K	0.04%	392
2021 Q2	$275K	Buy	2,969 +486	+20%	+$41.3K	0.04%	367
2021 Q1	$220K	Buy	+2,483	New	+$246K	0.04%	393

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Main Street Financial Solutions's ARKG Position: Q1 2022 in Review

Main Street Financial Solutions sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 3,288 shares — an estimated $201K sold.

Main Street Financial Solutions first reported a position in ARKG in Q1 2021 and held it in 4 quarters. The position peaked at $275K in Q2 2021. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Main Street Financial Solutions reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Main Street Financial Solutions sold 3,288 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $201K.
Main Street Financial Solutions first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 4 quarters.
Main Street Financial Solutions's ARK Genomic Revolution ETF position peaked at $275K in Q2 2021.
387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Main Street Financial Solutions's 13F filing for Q1 2022, filed 22 Apr 2022.